INDO US BIOTECH LTD Valuation
INDOUS · Fast Moving Consumer Goods · Current price ₹78.99
Is INDO US BIOTECH LTD undervalued?
DocStoX estimates the fair value of INDO US BIOTECH LTD at ₹125 per share, versus the current market price of ₹79. That puts the stock about +58.1% below our fair-value estimate, which we read as "Strong Buy". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹47), Relative P/E (₹304), Graham floor (₹83). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹47 (bear) to ₹125 (base) to ₹304 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Valuation multiples
INDO US BIOTECH LTD trades at a P/E of 12.1x and a P/B of 1.8x, with a dividend yield of 0.3%. Multiples are most useful compared against the company's own history and its sector peers — see the peer comparison for context.
Understand the ratios
More on INDO US BIOTECH LTD
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.